Summary by Moomoo AI
Hua Ling Pharmaceutical announced that the Board of Directors meeting will be held on March 27, 2025 (Thursday), with the main agenda including reviewing the annual performance of the group for the year ending December 31, 2024, as well as discussing the proposed final dividend matters (if any).The meeting will be chaired by Dr. Chan Li, the Chief Executive Officer and Executive Director, and the Board of Directors will also address other related matters at that time.
Comment(0)
Reason For Report